Announcements Trials
Browse Landscape

Phase

Phase 2/3 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 24Endocrine 24Thoracic 6Gynecologic 6Gastrointestinal 3CNS 3Plasma cell 2Other hematologic neoplasm 2NET 2Myeloid 2Dermatologic 2Sarcoma 1Lymphoid 1Genitourinary 1Breast 1

Conditions

Myelodysplastic Syndromes 361Leukemia, Myeloid, Acute 302Myeloproliferative Disorders 155Leukemia, Myelogenous, Chronic, BCR-ABL Positive 142Precursor Cell Lymphoblastic Leukemia-Lymphoma 115Primary Myelofibrosis 103Leukemia, Myelomonocytic, Chronic 89Lymphoma, Non-Hodgkin 76Leukemia 71Polycythemia Vera 64Multiple Myeloma 55Hodgkin Disease 50Hematologic Neoplasms 49Leukemia, Lymphocytic, Chronic, B-Cell 44Leukemia, Biphenotypic, Acute 41Thrombocythemia, Essential 40Lymphoma 40Myelodysplastic-Myeloproliferative Diseases 32Neoplasms 29Leukemia, Myeloid, Chronic-Phase 28Anemia, Refractory, with Excess of Blasts 24Recurrence 23Anemia, Aplastic 21Lymphoma, Mantle-Cell 20Lymphoma, Follicular 20Hematologic Diseases 20Burkitt Lymphoma 20Blastic Plasmacytoid Dendritic Cell Neoplasm 20Blast Crisis 20Histiocytosis, Langerhans-Cell 19

Interventions

trametinib 1dabrafenib 1cobimetinib 1Vemurafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Thyroid Carcinoma, Anaplastic × Myeloid × 1 year × Clear all
NCT07440290 2026-02-27

DETERMINE

Cancer Research UK

Phase 2/3 Not yet recruiting
30 enrolled
CNSEndocrineGastrointestinalGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Glioma, Histiocytosis, Langerhans-Cell, Laryngeal Neoplasms, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

NCT05768178 2025-11-24

DETERMINE

Cancer Research UK

Phase 2/3 Recruiting
30 enrolled
CNSDermatologicEndocrineGastrointestinalGynecologicHead & NeckMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Glioma, Laryngeal Neoplasms, Melanoma, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡